# 05 UC10 Dataset Suitability Matrix

| UC10 Requirement | Architecture A (Ben+FFS+PDE) | Architecture B (Ben+FFS+PrvDrug) | Winner |
|---|---|---|---|
| Completeness | 5 | 5 | TIE |
| Validity | 5 | 5 | TIE |
| Uniqueness | 5 | 5 | TIE |
| Referential Integrity | 5 | 0 | ARCH A (100% vs 0% match) |
| Cross-dataset validation | 5 | 0 | ARCH A |
| Volume anomaly | 5 (Daily trends) | 1 (Simulated only) | ARCH A |
| Distribution anomaly | 4 | 2 | ARCH A |
| Multivariate anomaly | 5 | 1 | ARCH A (Event-level IF possible) |
| Isolation Forest | 5 | 1 | ARCH A |
| RCA | 5 | 1 | ARCH A (Can isolate to BENE_ID) |
| Impact analysis | 5 | 1 | ARCH A (Precise cohort identification) |
| SLA simulation | 3 | 3 | TIE |
| Claim-level investigation | 5 | 0 | ARCH A |
| Provider-level analysis | 4 | 5 | ARCH B (Better real-world provider data) |
| Drug-level analysis | 4 | 5 | ARCH B (Real drug names vs codes) |
| RAG structured evidence | 5 | 2 | ARCH A (Clear lineage) |
| Explainability | 5 | 2 | ARCH A |
| Prototype complexity | 4 | 2 | ARCH A (No forced joins) |
| Computational cost | 3 | 2 | ARCH A (PDE is smaller than 3GB Part D) |
| 2-day feasibility | 5 | 2 | ARCH A |
